| PERIOD ENDING | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | 29-Jun-08 | | Total Revenue | 2,775 | 2,841 | 2,744 | 8,561 | | Cost of Revenue | 2,028 | 2,418 | 2,315 | 6,360 | | | Gross Profit | 746 | 423 | 428 | 2,201 | | | Operating Expenses | | Research Development | 531 | 436 | 350 | 455 | | Selling General and Administrative | 2,863 | 2,259 | 1,861 | 3,156 | | Non Recurring | (8) | (8,633) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,640) | 6,361 | (1,783) | (1,410) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5 | 15 | 32 | 316 | | Earnings Before Interest And Taxes | (2,635) | 6,376 | (1,752) | (1,095) | | Interest Expense | 218 | 831 | 409 | 1,511 | | Income Before Tax | (2,853) | 5,545 | (2,161) | (2,605) | | Income Tax Expense | (308) | 410 | 19 | 4 | | Minority Interest |
-
|
-
| 0 | 0 | | | | Net Income From Continuing Ops | (2,545) | 5,135 | (2,179) | (2,609) | | | Non-recurring Events | | Discontinued Operations |
-
| (7) | 65 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,545) | 5,128 | (2,114) | (2,609) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,545) | $5,128 | ($2,114) | ($2,609) |
|
0.51% Nasdaq 
0.01 (2.75%) 
Income Statement
